SCHEMBL7414009

SCHEMBL7414009

CN(C(=O)C(CC1CCCCC1)NC(=O)c1ccccc1F)C1(C#N)CCNCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.46
CTSS P25774 9/20 0.43
CTSL P07711 7/20 0.43
CTSB P07858 3/20 0.43
CTSK P43235 2/20 0.43
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PSEN1 P49768 4/20 0.35
PSEN2 P49810 4/20 0.35
APH1B Q8WW43 4/20 0.35
NCSTN Q92542 4/20 0.35
APH1A Q96BI3 4/20 0.35
PSENEN Q9NZ42 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417185 0.88 CTSL (0.57) USP30CTSSCTSLCTSBCTSK
SCHEMBL7410718 0.82 CTSS (0.47) USP30CTSSCTSLCTSBCTSK
SCHEMBL7409657 0.82 CTSS (0.60) USP30CTSSCTSLCTSBCTSK
SCHEMBL7026883 0.81 CTSS (0.52) CTSSCTSLCTSBCTSKNPC1
SCHEMBL7414894 0.80 CTSS (0.45) USP30CTSSCTSLCTSBCTSK
SCHEMBL7414674 0.79 CTSS (0.45) USP30CTSSCTSLCTSBCTSK
SCHEMBL5530633 0.75 CTSS (0.74) USP30CTSSCTSLCTSBCTSK
SCHEMBL5375073 0.73 CTSS (0.60) USP30CTSSCTSLCTSBCTSK
SCHEMBL7414874 0.71 CTSS (0.46) USP30CTSSCTSLCTSBCTSK
SCHEMBL7561468 0.71 CTSS (0.53) USP30CTSSCTSLCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed